HilleVax, Inc.
HLVXDelisted Sep 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001888012
HilleVax, Inc. was delisted on Sep 17, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 74 institutions reported holding it in 13F filings for Q2 2025, worth $82.5M in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in HilleVax, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
HLVX is no longer listed, and 13F filings after Q2 2025 list far fewer holders. See Q2 2025
- Institutional holders
- 1
- −73 vs. Q2 2025
- Shares held
- 179.2K
- −41.3M (−99.6%) vs. Q2 2025
- Total value
- $0
- −$82.5M (−100.0%) vs. Q2 2025
- New holders
- 0
- 1 more added
- Sold out
- 73
- 0 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HLVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 74 | $82.5M |
| Q1 2025 | 81 | $61.1M |
| Q4 2024 | 76 | $88.7M |
| Q3 2024 | 79 | $73.5M |
| Q2 2024 | 94 | $657.8M |
| Q1 2024 | 81 | $730.0M |
| Q4 2023 | 69 | $678.3M |
| Q3 2023 | 68 | $459.3M |
| Q2 2023 | 54 | $436.6M |
| Q1 2023 | 61 | $436.2M |
| Q4 2022 | 55 | $440.2M |
| Q3 2022 | 51 | $399.9M |
| Q2 2022 | 57 | $253.7M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding HilleVax, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 179,184 | $0 | 0.00% | +136,431+319.1% | Added |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −10,617,062−100.0% | Sold out |
| Takeda Pharmaceutical Co Ltd | 0 | $0 | 0.00% | −6,724,000−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −4,920,000−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −2,420,243−100.0% | Sold out |
| Lightspeed Management Company, L.L.C. | 0 | $0 | 0.00% | −2,303,871−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −1,953,642−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,882,654−100.0% | Sold out |
| Carlyle Group Inc. | 0 | $0 | 0.00% | −1,838,486−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −1,451,205−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −976,297−100.0% | Sold out |
| StepStone Group LP | 0 | $0 | 0.00% | −826,569−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −460,505−100.0% | Sold out |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −399,637−100.0% | Sold out |
| Trium Capital LLP | 0 | $0 | 0.00% | −395,188−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −387,533−100.0% | Sold out |
| Qiming U.S. Ventures Management, LLC | 0 | $0 | 0.00% | −372,615−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −314,468−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −308,595−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −255,254−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −226,009−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −211,600−100.0% | Sold out |
| RBF Capital, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −176,327−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −174,906−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −170,209−100.0% | Sold out |
| Rangeley Capital, LLC | 0 | $0 | 0.00% | −153,790−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −110,264−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −109,153−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −92,803−100.0% | Sold out |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −91,913−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −78,466−100.0% | Sold out |
| Militia Capital Partners, LP | 0 | $0 | 0.00% | −71,606−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −62,134−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −61,997−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −61,542−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −54,100−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −49,963−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −43,219−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −37,625−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −34,324−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −30,942−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −30,257−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −30,196−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −26,493−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −26,467−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −23,939−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −22,986−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −21,400−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −19,331−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −18,565−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −17,235−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −16,453−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,106−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −13,411−100.0% | Sold out |
| Callan Family Office, LLC | 0 | $0 | 0.00% | −11,734−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,606−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −7,360−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −4,232−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −3,102−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2,598−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −1,446−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1,098−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −805−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −929−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −836−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −449−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −353−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −207−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −147−100.0% | Sold out |
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |